Evidence map›Paper›PMID 32206316›Full record

Observational studyOpen heart2020

Association of hyperlipidaemia with 5-year survival after hospitalisation for acute myocardial infarction: a propensity score matched analysis.

Mohammed Yousufuddin, Ye Zhu, Ruaa Al Ward, Jessica Peters, Taylor Doyle, Kelsey L Jensen, Zhen Wang, Mohammad Hassan Murad

Open access · goldFull text readObservational Study
In one paragraph

Observational study in Open heart, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mohammed YousufuddinInternal Medicine, Mayo Clinic Health System, Austin, Minnesota, USA.ORCID 0000-0002-7496-9856
Ye ZhuCenter for the Science of Health Care Delivery, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Ruaa Al WardInternal Medicine, Mayo Clinic Health System, Austin, Minnesota, USA.
Jessica PetersInternal Medicine, Mayo Clinic Health System, Austin, Minnesota, USA.
Taylor DoyleInternal Medicine, Mayo Clinic Health System, Austin, Minnesota, USA.
Kelsey L JensenInternal Medicine, Mayo Clinic Health System, Austin, Minnesota, USA.
Zhen WangHealth Care Policy & Research, Mayo Clinic, Rochester, Minnesota, USA.
Mohammad Hassan MuradPreventive Medicine and Center for the Science of Health Care Delivery, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Mayo Clinic Health System · USMayo Clinic · USMayo Clinic in Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The primary objective was to examine the association between hyperlipidaemia (HLP) and 5-year survival after incident acute myocardial infarction (AMI). The secondary objectives were to assess the effect of HLP on survival to discharge across patient subgroups, and the impact of statin prescription, intensity and long-term statin adherence on 5-year survival. Methods: Retrospective cohort study of 7071 patients hospitalised for AMI at Mayo Clinic from 2001 through 2011. Of these, 2091 patients with HLP (age (mean±SD) 69.7±13.5) were propensity score matched to 2091 patients without HLP (age 70.6±14.2). Results: In matched patients, HLP was associated with higher rate of survival to discharge than no HLP (95% vs 91%; log-rank <0.0001). At year 5, the adjusted HR for all-cause mortality in patients with HLP versus no HLP was 0.66 (95% CI 0.58-0.74), and patients with prescription statin versus no statin was 0.24 (95% CI 0.21 to 0.28). The mean survival was 0.35 year greater in patients with HLP than in those with no HLP (95% CI 0.25 to 0.46). Patients with HLP gained on an average 0.17 life year and those treated with statin 0.67 life year at 5 years after AMI. The benefit of concurrent HLP was consistent across study subgroups. Conclusions: In patients with AMI, concomitant HLP was associated with increased survival and a net gain in life years, independent of survival benefit from statin therapy. The results also reaffirm the role of statin prescription, intensity and adherence in reducing the mortality after incident AMI.

Indexed as

HospitalizationAgedAged, 80 and overBiomarkersFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHyperlipidemiasLipidsMaleMiddle AgedMinnesotaNon-ST Elevated Myocardial InfarctionPrognosisPropensity ScoreRetrospective StudiesBiomarkersHydroxymethylglutaryl-CoA Reductase InhibitorsLipidsacute myocardial infarctionhyperlipidaemiamortalitystatinsurvival

Identifiers

PMID32206316
PMCPMC7078940
OpenAlexW3012015781

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.